---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-034328"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2022-06-22T23:59:59+00:00"
generated_at: "2026-06-24T23:51:15.974960+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CPHI receives NYSE American delisting notice for insufficient stockholders' equity

## Summary
- Stockholders' equity was $5.3M as of March 31, 2022, below the $6.0M minimum required under Section 1003(a)(iii).
- Company must submit a compliance plan by July 15, 2022 to regain compliance by December 15, 2023.
- CPHI stock will continue trading on NYSE American under symbol CPHI with added '.BC' designation.
- Failure to submit or comply with the plan may result in commencement of delisting proceedings.

## SEC filing metadata
- accession: 0001213900-22-034328
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2022-06-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/0001213900-22-034328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/ea161911-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-034328
- JSON: https://secwatch.observer/filing/0001213900-22-034328.json
- Plain text: https://secwatch.observer/filing/0001213900-22-034328.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.